Metronidazol B. Braun

Metronidazole, the active ingredient in Metronidazol B. Braun, is a nitroimidazole antibiotic presented as an injectable solution for intravenous use. It treats anaerobic bacterial and protozoal infections in adults and children as prescribed by a healthcare professional.

GNH USA supplies Metronidazol B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is employed for a range of anaerobic and protozoal infections. - Intra‑abdominal infections: eliminates anaerobic bacteria, supporting resolution of peritonitis and abscesses. - Pelvic inflammatory disease: targets mixed aerobic‑anaerobic flora to reduce pelvic inflammation. - Bacterial vaginosis: restores vaginal flora by eradicating Gardnerella and related organisms. - Clostridioides difficile infection: suppresses toxin‑producing bacteria in the colon. - Amoebiasis and other protozoal infections: kills Entamoeba histolytica and related parasites.

Metronidazole may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Metallic taste: transient metallic sensation in the mouth. - Headache: mild to moderate headache. - Diarrhea: loose stools, often self‑limiting. - Abdominal pain: cramping or discomfort. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Seizures: rare neurologic events. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: severe skin blistering. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Pancytopenia: reduced blood cell counts.

Before initiating therapy, clinicians should consider several safety factors. - Renal function assessment: adjust dose in severe renal impairment. - Hepatic monitoring: observe liver enzymes during prolonged use. - Pregnancy considerations: avoid in the first trimester unless benefits outweigh risks. - Alcohol avoidance: prevent disulfiram‑like reactions. - Concomitant CNS depressants: use with caution due to additive sedation. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze.

Metronidazole can interact with several medicines, requiring attention to the interaction level.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, tachycardia, and hypotension. - Warfarin: increased anticoagulant effect, risk of bleeding. - Lithium: heightened lithium toxicity.

Moderate Interactions (Monitor Closely): - Phenytoin: may reduce metronidazole plasma concentrations. - Cimetidine: can increase metronidazole levels, enhancing toxicity. - Carbamazepine: enzyme induction may lower metronidazole efficacy.